Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1681/ASN.2014030227 http://scihub22266oqcxt.onion/10.1681/ASN.2014030227 C4413760!4413760!25255922     free     free     free       J+Am+Soc+Nephrol 2015 ; 26 (5): 1017-9 Nephropedia Template TP {{tp|p=25255922|t=2015. Reassessing Medical Risk in Living Kidney Donors |pdf=|usr=}}{{25255922}} gab.com Text Reassessing Medical Risk in Living Kidney Donors JO: J Am Soc Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=25255922 #FOAvip The short- and long-term effects of unilateral nephrectomy on living donors have been important considerations for 60 years. Short-term risk is well established (0.03% mortality and <1% risk of major morbidity), but characterization of long-term risk is evolving. Relative to the general population, risk of mortality, ESRD, hypertension, proteinuria, and cardiovascular disease is comparable or lower. However, new studies comparing previous donors with equally healthy controls indicate increased risk of metabolic derangements (particularly involving calcium homeostasis), renal failure, and possibly, mortality. We discuss how these results should be interpreted and their influence on the practice of living donor kidney transplantation. Twit Text FOAVip Reassessing Medical Risk in Living Kidney Donors ????J Am Soc Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=25255922 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25255922 #FOAvip English Wikipedia <ref>{{Cite pmid|25255922}}</ref> Reassessing Medical Risk in Living Kidney Donors #MMPMID25255922 Gaston RS; Kumar V; Matas AJ J Am Soc Nephrol 2015[May]; 26 (5): 1017-9 PMID25255922show ga The short- and long-term effects of unilateral nephrectomy on living donors have been important considerations for 60 years. Short-term risk is well established (0.03% mortality and <1% risk of major morbidity), but characterization of long-term risk is evolving. Relative to the general population, risk of mortality, ESRD, hypertension, proteinuria, and cardiovascular disease is comparable or lower. However, new studies comparing previous donors with equally healthy controls indicate increased risk of metabolic derangements (particularly involving calcium homeostasis), renal failure, and possibly, mortality. We discuss how these results should be interpreted and their influence on the practice of living donor kidney transplantation. äReassessing Medical Risk in Living Kidney Donors (epmc).pdf DeepDyve Pubget Overpricing